| PU21.02 | Comparison of HIV incidence in simulated vaccine efficacy trials and observational cohorts using propensity scores in key populations in Uganda | Publication Only | Novel vaccine and other prevention approaches |
| OA05.03 | Compartment specific changes of Innate Lymphoid Cells within the intestinal mucosa of HIV-1 infected individuals | Oral Abstract Session | Microbiome & STI: impact on prevention |
| OA19.02 | Construction of a comprehensive bacterial genome catalogue for the female genital tract identifies hundreds of new species | Oral Abstract Session | Microbiome & STI: impact on prevention |
| PE06.01 | Contraceptive uptake among adolescent girls and young women pre-screened for the MTN-034/ REACH study | E-poster | Contraception, pregnancy and HIV prevention (incl. PMTCT) |
| PU25.02 | Correlates of adherence to the dapivirine vaginal ring for HIV-1 prevention | Publication Only | Product acceptability and adherence |
| PE04.01 | Correlates of dapivirine vaginal ring uptake among women participating in an open label extension trial-MTN-025/HOPE | E-poster | Clinical trial results |
| OA02.02 | Correlates of high HIV transmission areas in a generalized hyperendemic setting: findings from a national survey in Eswatini | Oral Abstract Session | Treatment as prevention |
| PE19.04 | Correlates of STI acquisition during the first years after sexual initiation: a longitudinal cohort study of sexually inexperienced adolescent girls and young women in Kenya | E-poster | Microbiome & STI: impact on prevention |
| PE01.19 | Counselors’ acceptability of adherence counseling session recording, fidelity monitoring, and feedback in a multi-site HIV prevention study in four African countries | E-poster | Behavioural and social science research |
| PE07.01 | COVID-19 and associated disruptions may indirectly affect HIV outcomes in two capital cities in Western/Central Africa: a modelling study | E-poster | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |